Navigation Links
Study describes health effects of occupational exposures in Paducah Gaseous Diffusion Plant workers
Date:7/22/2010

A five-year study into the causes of deaths of workers at Paducah Gaseous Diffusion Plant (PGDP) shows significantly lower death rates from all causes and cancer in general when compared to the overall United States population. This is known by occupational health researchers as the "healthy worker effect". However, death from lymphatic and bone marrow cancers such as leukemia or multiple myeloma were slightly above national rates.

The study was conducted by faculty at the University of Louisville School of Public Health and Information Sciences and collaborators from the University of Cincinnati and the University of Kentucky. It was funded through the National Institute for Occupational Safety and Health, thanks to the effort of U.S. Senator Mitch McConnell, who was instrumental in getting the study off the ground.

"This was an important study, because it addressed lingering concerns about the health of workers at the Paducah Gaseous Diffusion Plant," said David Tollerud, MD, MPH, professor of environmental and occupational health sciences at UofL's School of Public Health and Information Sciences. "It is important for occupational health and public health research to attempt to answer pressing concerns of impacted populations, and we were able to report that we didn't find unexpectedly high rates of disease in this workforce."

Security workers had higher overall death rates than other employees, while chemical operators had higher death rates from leukemia and multiple myeloma than the rest of the workers.

"The increased number of lymphatic and bone marrow cancer deaths is consistent with what we expected. Based on other studies, these forms of cancer have been linked to low levels of radiation exposure," Tollerud said.

The team compiled data on thousands of employees who worked at the plant for at least 30 days in different job classifications from 1952 through 2003. The data were used to assess exposure levels. Overall, 1,638 workers died out of the 6,759 in the study. This is less than the 2,253 deaths that would have been expected in the general public during the same time.

The team now plans to present its findings to PGDP workers and distribute a study fact sheet that summarizes the main findings and directs workers to resources that are available if they have concerns or questions.

The Paducah Gaseous Diffusion Plant, located in western Kentucky, is the only operating uranium enrichment facility in the United States, and the only one where a worker mortality study had not been conducted. The plant was commissioned in 1952 under the U.S. Department of Energy as part of a U.S. government program to produce enriched uranium to fuel military reactors and nuclear weapons. The plant's mission changed in the 1960s from enriching uranium for nuclear weapons to enriching uranium for use in commercial nuclear reactors to generate electricity.


'/>"/>

Contact: Julie Heflin
julie.heflin@louisville.edu
502-852-7987
University of Louisville
Source:Eurekalert

Related medicine news :

1. Study links more time spent sitting to higher risk of death
2. NIH-funded study finds early HAART during TB treatment boosts survival rate in co-infected people
3. Study Points to Molecular Origins of Celiac Disease
4. FDA Puts Partial Hold on Avandia Safety Study
5. Not Every ACL Tear Needs Early Surgery, Study Suggests
6. Most men in long-term study of HIV report low use of illicit drugs
7. Gladstone and Lundbeck collaborate to study neurovascular disease
8. New Study Finds HPV Vaccine Protects Against Genital Warts
9. Vaginal Gel Cuts Risk of HIV Infection, Study Shows
10. Research consortium at CHLA receives $410,000 to study leukemia and lymphoma
11. Concordia researcher leads study that finds kids reduce physical activity for heart patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... With the number of pain management programs ... patients must find the one that works for them. When an inventor from Suisun ... that worked and decided to share it with others. , He developed a prototype ...
(Date:12/2/2016)... ... December 02, 2016 , ... Dr. Raffi Hovsepian, a leading ... the 2016 “Guide to America’s Top Plastic Surgeons” for seven consecutive years. The ... education, experience, and professional associations. , One the most frequently honored surgeons ...
(Date:12/2/2016)... ... 2016 , ... Mediaplanet is proud to announce the launch ... innovative treatments, therapeutic technologies, and revolutionized nutrition that are helping patients and physicians ... years in the last 3 decades,” says Dr. Valentine Fuster, a world-renowned cardiologist. ...
(Date:12/2/2016)... ... December 02, 2016 , ... The PAINWeekEnd Regional Conference will ... Spa in Honolulu, offering local frontline clinicians the opportunity to extend their certified ... demand for supplemental training related to pain management has surged dramatically in recent ...
(Date:12/2/2016)... ... December 02, 2016 , ... Sourced from the Isbre Springs beneath the 5,000 ... unmatched natural purity of just 6 ppm TDS (Total Dissolved Solids) in addition to ... been available in several ShopRite and FoodTown stores in NJ and received rave comments ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... -- Lianluo Smart Limited (Nasdaq: LLIT ... markets and sells medical devices and wearable sleep ... and international markets, recently attended the 2016 Guangdong ... Forum, co-hosted by the Institute of Interventional Cardiology ... Provincial People,s Hospital and Cardiology Department of Guangdong ...
(Date:12/2/2016)... Dec. 1, 2016 The concept of rare diseases ... given to this sector has been taking shape in ... the political aspects and initiatives related to orphan medicinal products ... the level of member states individually. Many member states in ... the space of orphan medicinal products, the result of which ...
(Date:12/2/2016)... Dec. 2, 2016 Allergan plc (NYSE: ... information on its previously announced Accelerated Share Repurchase (ASR) Program. ... ... As previously announced, the Company entered into a ... the Company will repurchase $10 billion of its ordinary shares. ...
Breaking Medicine Technology: